Therapeutic strategies to block LPS interactions with its receptor.
R.W. Johnson Pharmaceutical Research Institute, San Diego, CA 92121, USA.
D J
DJ
Leturcq
A M
AM
Moriarty
G
G
Talbott
R K
RK
Winn
T R
TR
Martin
R J
RJ
Ulevitch
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001794:Blood Pressure; D016207:Cytokines / Q000097:blood; D004195:Disease Models, Animal; D006801:Humans; D018950:Lipopolysaccharide Receptors / Q000276:immunology* / Q000378:metabolism; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000633:toxicity; D008252:Macaca fascicularis; D012772:Shock, Septic / Q000209:etiology / Q000503:physiopathology / Q000628:therapy
D000911:Antibodies, Monoclonal; D016207:Cytokines; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides